筛查性数字乳腺断层摄影中放射状瘢痕的升期率与管理策略
回顾性研究纳入2013年1月1日至2020年12月31日筛查性DBT和DM后空心针活检示放射状瘢痕的153例女性159个病灶,总体升期率5.0%(8/159),无 atypia 者1.6%(2/129)vs 伴 atypia 者20.0%(6/30),p<.001;作者认为无 atypia 者尤其表现为钙化者可影像随访而非手术。
要点
- DBT筛查检出的放射状瘢痕总体升期率5.0%(8/159),伴atypia者升期率20.0%(6/30)高于无atypia者1.6%(2/129)。
- 既往乳腺癌病史者升期率62.5% vs 无此病史者4.8%(p=.01),CNB伴atypia者75.0% vs 无atypia者15.9%(p=.02)。
- 按钼靶表现类型升期率:不对称7.1%(1/14)、肿块12.5%(2/16)、结构扭曲5.3%(5/95)、钙化0.0%(0/34)。
核心结论
- 筛查性DBT检出的CNB无atypia放射状瘢痕升期为乳腺癌的比率低(1.6%);作者认为对无atypia的放射状瘢痕尤其表现为钙化者,影像随访而非手术是合理方法。
研究设计与样本
- 回顾性研究,纳入2013年1月1日至2020年12月31日筛查性DBT和DM后CNB示放射状瘢痕的患者;最终样本为153例女性159个放射状瘢痕(平均年龄56岁,范围33-83岁),其中80.5%(128/159)行手术切除、19.5%(31/159)行至少2年影像随访;排除CNB后未手术切除且无至少2年影像随访者。
关键影像表现/征象
- 按钼靶表现类型,放射状瘢痕升期率分别为不对称7.1%(1/14)、肿块12.5%(2/16)、结构扭曲5.3%(5/95)、钙化0.0%(0/34)。
诊断标准与关键数值
- 升期定义为CNB示放射状瘢痕后手术或随访证实为乳腺癌(导管原位癌[DCIS]或浸润性疾病)。
- 总体升期率5.0%(8/159),其中7个升期为DCIS、1个升期为浸润性疾病。
- CNB无atypia者升期率1.6%(2/129),伴atypia者20.0%(6/30),p<.001。
- 多变量分析中与升期风险较高相关的因素包括既往乳腺癌诊断(62.5% vs 4.8%;p=.01)和CNB伴atypia(75.0% vs 15.9%;p=.02)。
临床应用与阅片要点
- 作者认为对CNB无atypia的放射状瘢痕,影像随访而非手术是合理方法,尤其适用于表现为钙化者。
- 原文未据此给出伴atypia或既往乳腺癌病史者的具体管理推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Radial scars are more commonly identified on digital breast tomosynthesis (DBT) than on digital mammography (DM). Nonetheless, universal guidelines for radial scar management in the current era of DBT are lacking. OBJECTIVE. The purpose of this study was to determine the upstaging rates of screening DBT-detected radial scars with and without atypia and to identify features related to upstaging risk. METHODS. This retrospective study included patients who underwent core needle biopsy (CNB) showing a radial scar after screening DBT and DM from January 1, 2013, to December 31, 2020. Patients without surgical excision or at least 2 years of imaging follow-up after CNB were excluded. Rates of upstaging to breast cancer (ductal carcinoma in situ [DCIS] or invasive disease) were compared between radial scars with and without atypia at CNB. Associations of upstaging with patient, imaging, and pathologic variables were explored using standard statistical tests. RESULTS. Of 165 women with 171 radial scars, the final study sample included 153 women (mean age, 56 years; range, 33-83 years) with 159 radial scars that underwent surgical excision (80.5%, 128/159) or at least 2 years of imaging follow-up (19.5%, 31/159). Seven radial scars were upstaged to DCIS and one to invasive disease. Therefore, the up-staging rate of radial scars to cancer was 5.0% (8/159). The upstaging rate of radial scars without atypia at CNB was 1.6% (2/129) and that of radial scars with atypia was 20.0% (6/30) (p < .001). On multivariable analysis, features associated with higher upstaging risk included a prior breast cancer diagnosis (62.5% vs 4.8%; p = .01) and the presence of atypia at CNB (75.0% vs 15.9%; p = .02). The upstaging rate according to mammographic finding type was 7.1% (1/14) for asymmetries, 12.5% (2/16) for masses, 5.3% (5/95) for architectural distortion, and 0.0% (0/34) for calcifications. CONCLUSION. Screening-detected radial scars without atypia at CNB have a low upstaging rate to breast cancer of 1.6%. CLINICAL IMPACT. Imaging surveillance rather than surgery is a reasonable approach for radial scars without atypia, particularly for those presenting as calcifications.
引用
- Crowley C, Bahl M. Radial Scars on Screening Digital Breast Tomosynthesis: Upstaging Rates and Management Strategies. AJR Am J Roentgenol. 2024. PMID: 38477526. doi:10.2214/AJR.24.30845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。